U.S., July 30 -- An application to own the trademark for 'ETCAMAH' has been filed on May. 29, 2025.
Owner(s):
AstraZeneca AB; Astraallen, , SWEDEN
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal, and immune systems; Vaccines; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Antibodies for medical purposes; Pharmaceutical preparations for use in oncology
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-07-29&serialNumber...